EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

S3 guideline diagnostics and therapy of alopecia areata – Part 1: Diagnostics and epidemiology

Ulrike Blume-Peytavi iD, Andria Constantinou iD, Tsenka Tomova-Simitchieva iD, Adrian Tanew iD, Michael Sticherling iD, Hermann Girschick iD, Annika Vogt iD, Uwe Schwichtenberg, Uwe Gieler iD, André Märtens, Kerstin Zienert, Claudia Stenders und 2 weitere

JDDG: Journal der Deutschen Dermatologischen Gesellschaft · 2026-07 · 24 (7)

DOI: 10.1111/ddg.70065x ↗

Kurz gefasst

Leitlinie in der Zeitschrift JDDG: Journal der Deutschen Dermatologischen Gesellschaft, online erschienen am 19.03.2026. Verfasst von Ulrike Blume-Peytavi und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humbol…. Hauptthemen laut MEDLINE: Alopecia Areata. Die Arbeit nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the project funded by the Innovation Committee at the G‐BA, the S3 guideline for the diagnosis and treatment of AA was developed between 2023 and 2025. The interdisciplinary expert panel consisted of representatives from the German Dermatological Society, in particular from the Pediatric Dermatology Working Group, the Professional Association of German Dermatologists, the German Society for Psychosomatic Medicine and Psychotherapy, the German Society for Pediatrics and Adolescent Medicine, the Austrian Society for Dermatology and Venereology, a hairdresser as an external consultant and two patient representatives. In the first of two parts, we present the key statements on epidemiology and the recommendations for diagnosis. Data from Germany show a population‐based prevalence of AA of 0.22% (95% CI 0.21–0.22) for 2016 and 0.21% (95% CI 0.20–0.22) for 2020. This means that 170,000 people in Germany were diagnosed with alopecia areata (AA) in 2020. International data show a pooled prevalence of 2.1%, but with large regional differences. Data on the incidence of AA from Germany show that 72 patients per 100,000 were newly diagnosed with AA in 2020 (RR 0.072%; 95% CI 0.07–0.08). Extrapolated to the German population, this means that around 70,000 people were newly diagnosed with AA in 2020.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alopecia AreataHumansGermanyPrevalenceAdolescentFemaleMaleChildIncidenceAdultDermatology

Stichwörter der Autor:innen

Alopecia areatacomorbiditiesdiagnosisepidemiologyprognostic factorsrisk factors

Autor:innen und Institutionen

  • Department of Dermatology, Venereology and Allergology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin Institute of Health, Berlin, Germany.
  • Private practice, Vienna, Austria.
  • Department of Dermatology, University Hospital Erlangen, Erlangen, Germany.
  • Department of Pediatrics and Adolescent Medicine, Vivantes Netzwerk für Gesundheit GmbH, Klinikum im Friedrichshain, Berlin, Germany.
  • Derma Nord Dermatology Practice, Bremen, Germany.
  • Psychodermatology Competence Center, University Hospital Giessen, Vitos Giessen-Marburg gemeinnützige GmbH, Vitos Psychosomatik Giessen, Giessen, Germany.

ORCID-Profile: Ulrike Blume-Peytavi, Andria Constantinou, Tsenka Tomova-Simitchieva, Adrian Tanew, Michael Sticherling, Hermann Girschick, Annika Vogt, Uwe Gieler, Ricardo Niklas Werner, Doris Wilborn

Zitieren

APA

Blume-Peytavi, U., Constantinou, A., Tomova-Simitchieva, T., Tanew, A., Sticherling, M., Girschick, H., Vogt, A., Schwichtenberg, U., Gieler, U., Märtens, A., Zienert, K., Stenders, C., Werner, R. N., & Wilborn, D. (2026). S3 guideline diagnostics and therapy of alopecia areata – Part 1: Diagnostics and epidemiology. JDDG: Journal der Deutschen Dermatologischen Gesellschaft, 24(7). https://doi.org/10.1111/ddg.70065x

Vancouver

Blume-Peytavi U, Constantinou A, Tomova-Simitchieva T, Tanew A, Sticherling M, Girschick H, et al. S3 guideline diagnostics and therapy of alopecia areata – Part 1: Diagnostics and epidemiology. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. 2026;24(7). doi:10.1111/ddg.70065x

BibTeX
@article{BlumePeytavi2026,
  author = {Blume-Peytavi, Ulrike and Constantinou, Andria and Tomova-Simitchieva, Tsenka and Tanew, Adrian and Sticherling, Michael and Girschick, Hermann and Vogt, Annika and Schwichtenberg, Uwe and Gieler, Uwe and Märtens, André and Zienert, Kerstin and Stenders, Claudia and Werner, Ricardo Niklas and Wilborn, Doris},
  title = {S3 guideline diagnostics and therapy of alopecia areata – Part 1: Diagnostics and epidemiology},
  journal = {JDDG: Journal der Deutschen Dermatologischen Gesellschaft},
  year = {2026},
  volume = {24},
  number = {7},
  doi = {10.1111/ddg.70065x}
}
Kostenlos starten →